Member Info for surprised

https://twitter.com/surprised_trade/status/1572110046519070720

Revenues & EBITDAX increased by 63% and 113%, cash + 40% US$161.6, interim divi to increase +10%, buy backs continue. We await resumption following inspection,( hence 74p & not 100p+) , strong financial position, no debt

"Jadestone delivered record financial results in the first half of 2022, with production increasing by c.50% compared to the first half of 2021, driven by a full period contribution from the Malaysian assets acquired in August 2021 and the impact of the Montara drilling programme in the second half of 2021, albeit offset by an unplanned shutdown at Montara early in 2022 due to a compressor engine failure. Revenues and adjusted EBITDAX increased by 63% and 113% respectively, due to the increase in production volumes and higher realised oil prices. As a result, we ended the period with a net cash balance of US$161.6 million, an increase of almost 40% compared to year-end 2021. Jadestone remains debt free.

remediation plan for the Montara Venture FPSO following defects identified earlier this year. The plan involves emptying, cleaning, inspecting and, where necessary, resolving any defects in the tanks and hull of the FPSO. ...........While we understand that the lack of a firm restart date is frustrating for many of our stakeholders, our focus is on the remediation plan and its successful execution which, in turn, will restore confidence in the significant remaining value we see at Montara
.
The balance sheet strength we have built in recent years, and the confidence in our existing asset portfolio and its planned growth, means we are well-positioned to weather the Montara shut-in without any anticipated impact on our investment programmes, inorganic growth, or near-term shareholder returns.

We expect capital expenditures for the year to be in line with guidance of US$90.0 - 105.0 million. We have also taken the decision to increase the interim dividend by 10% to US$3.0 million and, subject to market conditions, we intend to
complete the US$25.0 million share buyback programme

The Company continues to deliver on its growth strategy. In June, we took a final investment decision on the Akatara gas development on the Lemang PSC in Indonesia, with activity at the site now well underway. Separately, the acquisition of the outstanding 10% stake in the Lemang PSC is expected to complete soon. In July, we announced the acquisition of a non-operated interest in the producing Northwest Shelf ("NWS") oil project offshore Australia, and are making good progress towards closing this transaction in Q4 2022.

Our strong balance sheet underlines the success of our business model, supporting our planned investments for growth, and while the recent Montara asset incident is unfortunate, we are determined to fix it and deliver the original value proposition vindicating our strategy in the Asia Pacific region."

https://twitter.com/surprised_trade/status/1571408786438656011

Worth a listen, Fantasy politics, No plan, no business acumen. Can't set price for things you don't own (oil/gas) Windfall tax's increase prices, West needs to flood market with oil/gas over coming years (get drilling) Nations need secure 'primary' energy

https://smartermarketspod.com/winter-is-coming-episode-3-doomberg/

https://www.ft.com/content/ef4fb2b8-1b28-43f3-b34f-13e98c769e63

The US shale industry has warned it cannot rescue Europe with increased oil and gas supplies this winter. “There’s no bailout coming. Not on the oil side, not on the gas side.”

https://twitter.com/surprised_trade/status/1570519818427854848

Yellen says real risk of $100+ for oil despite current softened prices and a real risk of a further spike in prices in a few weeks as Russian oil ban takes full effect

https://www.ft.com/content/ef4fb2b8-1b28-43f3-b34f-13e98c769e63

Growth Investor Magazine 31.08.22

'Given that AIM has fallen 32% over the period and against
the backdrop of a challenging macroeconomic environment,
Totally should continue to prove a solid defensive investment,
while at the same time generating decent growth.

The NHS is under even more stress than usual and is likely to remain so
for several years due to the treatment backlog built up over
the pandemic, which underpins Totally’s growth opportunity.

Its 111 service and Urgent Care centres relieve pressure in
primary healthcare provision, while the main growth driver is
likely to be the evolving Insourcing business. This is where
the NHS commissions Totally to carry out diagnostic and
surgical procedures using NHS facilities. The division grew
to £10m revenue in the year to March from just £3m the prior
year. Margins were lower due to more diagnostic procedures
in the mix, but CEO Wendy Lawrence told us margins should
improve this year. There will also be a significant boost from
the Pioneer acquisition which will add over £5m revenue and
has a strong profile within the NHS.

The group also has a high degree of visibility from existing
multi-year contracts. Lawrence said she is also seeing a lot
more contract extensions, rather than having to re-tender
when a contract nears expiry. Management is focused
on high-quality provision and ensuring the systems and
processes are in place to ensure contracts are managed
effectively – which is crucial in the context of a business
where revenue has doubled in four years. BUY '

A reminder of the fundamentals and results of just a couple of weeks ago while the sp languishes behind...

PetroTal Announces Q2 2022 Financial and Operating Results

Seventh straight quarter of production growth

Generated nearly $100 million in net operating income in Q2 2022

PetroTal delivered solid Q2 2022 financial and operational performance highlighted by record production rates, record cash flow, and a robust balance sheet profile with a substantial net cash position.

Broker note..
' PetroTal’s cash position increased from US$77 mm as at the end of June (and ~US$50 mm at YE21) to ~US$115 mm as at August 15 is testimony to the free cashflow generative nature of the business. Note that this cash position excludes ~US$59 mm outstanding from Petroperu (expected to be received in 2023). • Well 11H is still producing in excess of 9,000 bbl/d, which is a good performance as the well was put on production at 9,550 bbl/d in early July. •

The shares continue to offer deep value and growth. We re-iterate our target price of £1.30 per share

We forecast that YE23 net cash will represent 90% of the current market cap. '

'CEO comments - Given our strong liquidity profile we are actively assessing the Company's ability to put in place an accretive shareholder return policy upon payout of the bonds, which we look forward to communicating about later in 2022.'

Simply excellent figures and cash generation

...and the share buy backs continue ;-)

or it's been repaired and the inspection confirms all done ok ?

https://twitter.com/surprised_trade/status/1569974733667553282

added to holding at 68.80p today

I added at 90p a few days before the rns re inspection of repair delay, today the sp is at 67p ?? the bigger pic is it's a well run business, generating large profits and cash and a temporary delay has provided even greater opportunity in these volatile markets

in business, particularly oil, as we know, delays and breakages etc occur...I doubt many folk invested in SQZ for it's huge cash generation, profitability etc are seeking to invest elsewhere on the basis of a small delay and particulalrly when the cost is offset, ....'small issie on a big ship' and not one that will upset the forward look or daily cash generation, profits etc ....

Investors Chronicle Alpha stock preview.... 01.08.22

'.. more must be done urgently to bust the patient backlog for NHS treatment. One way is to enlist more help from the private sector to reduce pressure on hospitals and help cut waiting lists. Purchasing private capacity is not new, the pandemic demanded unprecedented block-booking arrangements with private health care operators. However, given the staffing shortages across all sectors of the NHS, private health care companies are likely to play an even greater role in the future if the UK Government is going to service the public demand.

Despite being forecast to deliver in excess of 100 per cent earnings growth over the next two years, this company is tantalisingly priced on a 2023/24 forward PE ratio of just 10 times.

High demand isn’t going to change any time soon given record backlogs in the NHS and a buy-and-build strategy has created the infrastructure to deliver a range of services. For good measure, TLY is cash generative and has a cash rich balance sheet
A total package for profitable growth
Totally is strategically aligned with NHS policy: specifically, the group is focused on the delivery
of non-acute care components out of hospitals and closer to home, and trends towards
outsourcing and outcome-based commissioning. The approach is underpinned by five strategic
pillars:
? Delivering core market growth.
? Securing market share gains as the partner of choice.
? Driving synergies across a growing business.
? Building strong long-term strategic and operational relationships

Allenby expects the group to more than double pre-tax profit and earnings per share (EPS) to
£7.9mn and 4.16p, respectively, in the two years to 31 March 2024 based on revenue rising
from £127.4mn to £160mn. The predictions look well underpinned by the fundamentals
driving demand for the group’s services, and suggest that the shares – priced on modest
forward price/earnings ratios of 14 (2022/23) and 10 (2023/24) – offer material potential for a
re-rating. Moreover, a closer look at each operating division suggests that there could even be
upside to these bumper earnings estimate

There are sound prospects of further new awards, too. That’s because the Department of
Health and Social Care 2021 White Paper set out a major strategic shift away from the focus on
competition (a major part of the 2012 government reforms) and removed some competition
and procurement rules, too. It means that the NHS has more flexibility to deliver joined-up care
and promote the concept of partnerships with the private sector.
Under the new commissioning system, contracts are being awarded less through competitive
tendering and increasingly through partnerships with trusted and established private sector
providers. Totally is incredibly well placed to benefit as a preferred partner of the NHS and win
new contracts as a trusted supplier of high-quality services
Target price 70p ..'

it happens, in any business, a few weeks delay, costs off set by the Investment allowance, as you were, carry on and SQZ still banking cash daily :-)

Malcy's blog update ....
''.......Guidance about guidance though is allowed and a figure of 13/- boe/d is suggested but if production is resumed towards the end of 2022 then 11/- boe/d is more likely to be accurate. For the sake of numbers the latter may be a wiser choice.

Again as I said before this is not going to change reserves, there is no reservoir damage after all and despite this year being disappointing, it is transient and nav is extended not dropped.

Also Jadestone still does have one of the best managements in the sector as I have always said and whilst CEO Paul Blakeley is in charge elsewhere in the group it will be business as usual, hopefully with some M&A activity on the cards.

He will have been more than cross about this but the company does have a fine portfolio of assets and despite current frustration the expansion of the portfolio recently means that the outlook is for organic growth plus maybe a bit more. I will speak more after the results next week when I hope to chat to Paul.

Having said all that the 20% fall in the last two days I think offers an opportunity, I’m not going to bail out on Jadestone now but for choice I would be buying the stock now. ''

on the plus side they just secured £14m of contracts, not too shabby :-)

https://twitter.com/surprised_trade/status/1569442485990223874

IC highlighting excellent results today and a 500p target

...and the Buy backs continue ;-)

https://twitter.com/surprised_trade/status/1567795732962222086

sp amazingly disconnected once again from the figures/fundamentals..
broker note states - 'We forecast that YE23 net cash will represent 90% of the current market cap, Our target price £1.30'

https://twitter.com/surprised_trade/status/1567759455395119112

Totally's Urgent Care division secures multiple contract extensions totalling £14m

https://*********************/newsfeed/article/totally-plc-totally-s-urgent-care-secures-contract-extensions-1473816

Investors Chronicle and Broker both have 70p target sp.

RNS

Totally's Urgent Care division secures multiple contract extensions totalling c. £14m



Contract extensions support NHS urgent care services in the North East of England and London



Totally plc (AIM: TLY), a leading provider of frontline healthcare services, corporate fitness and wellbeing services across the UK and Ireland, has secured several contract extensions for the continued provision of urgent care services across England.



Totally's Urgent Care division, which is made up of Vocare Limited and Greenbrook Healthcare Limited, has signed:



· Five contract extensions across the North East of England and Yorkshire for the continued delivery of GP out of hours ("GPOOH") and clinical assessment services ("CAS"). The contracts run until 31 March 2023 with a total value of c. £7.3 million; and

· A contract extension for the continued delivery of an urgent treatment centre in South East London until 31 March 2023, valued at c. £6.4 million.



These extensions underpin recurring revenue by securing the continuation of existing contracts and demonstrate the excellent long-term relationships held between Totally and commissioners across the country.

New Health minister Terese Coffey has said her “A-B-C-D” priorities will involve focusing on ambulances & backlogs of routine treatment,along with Doctors and dentists...She is due to set out her plan for the NHS next week

https://www.thetimes.co.uk/article/ambulances-gps-and-dentists-top-therese-coffeys-to-do-list-mrm8mvgvq